Martin Baur
Overview
Explore the profile of Martin Baur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brandle T, Bruchez P, Colombier C, Baur M, Hohl L
Inter Econ
. 2022 Feb;
57(1):48-55.
PMID: 35194240
The ongoing coronavirus pandemic crisis as well as demographic and climate change pose major challenges for public finances. This article deals with the implications of demographic trends in Switzerland, i.e....
2.
Bertolo A, Baur M, Guerrero J, Potzel T, Stoyanov J
Sci Rep
. 2019 Feb;
9(1):2074.
PMID: 30765770
Mesenchymal stromal cells (MSC) are used in cell therapies, however cellular senescence increases heterogeneity of cell populations and leads to uncertainty in therapies' outcomes. The determination of cellular senescence is...
3.
Moser M, Schmassmann P, Noger M, Baur M, Nevzati E
World Neurosurg
. 2019 Feb;
125:e764-e773.
PMID: 30735867
Background: Preoperative magnetic resonance imaging with fat suppression (FS-MRI) is useful to detect bone marrow edema in osteoporotic vertebral fractures (OVFs) and thus can improve diagnostic accuracy and influence surgical...
4.
Capossela S, Bertolo A, Gunasekera K, Potzel T, Baur M, Stoyanov J
BMC Res Notes
. 2018 May;
11(1):333.
PMID: 29784013
Objective: During degeneration of the intervertebral disc ingrowth of blood vessels and nerves into the disc are associated with back pain. Vascular endothelial growth factors promote vasculogenesis by binding to...
5.
Bertolo A, Pavlicek D, Gemperli A, Baur M, Potzel T, Stoyanov J
J Stem Cells Regen Med
. 2018 Feb;
13(2):62-74.
PMID: 29391751
Immunomodulatory properties of mesenchymal stem cells (MSC) are key components of their successful applications in clinical setting. However, treatments based on MSC immunomodulation need understanding of cell characteristics before cell...
6.
Bertolo A, Capossela S, Frankl G, Baur M, Potzel T, Stoyanov J
Stem Cell Res Ther
. 2017 Jan;
8(1):3.
PMID: 28061861
Background: Human bone marrow-derived mesenchymal stem cells (MSC) are adult progenitor cells with great potential for application in cell-based therapies. From a cell-based therapy perspective, there are two limitations to...
7.
Bertolo A, Arcolino F, Capossela S, Taddei A, Baur M, Potzel T, et al.
Tissue Eng Part A
. 2015 Jul;
21(19-20):2618-28.
PMID: 26222829
Tissue engineering is a field in progressive expansion and requires constant updates in methods and devices. One of the central fields is the development of biocompatible, biodegradable, and injectable scaffolds,...
8.
Schlaefli P, Bertolo A, Malonzo C, Poetzel T, Baur M, Steffen F, et al.
J Vis Exp
. 2015 May;
(98).
PMID: 25938767
Mesenchymal stem cells (MSCs) - usually obtained from bone marrow - often require expansion culture. Our protocol uses clinical grade urokinase to degrade clots in the bone marrow and release...
9.
Bertolo A, Gemperli A, Gruber M, Gantenbein B, Baur M, Potzel T, et al.
Stem Cells Transl Med
. 2014 Dec;
4(1):84-90.
PMID: 25473086
Mesenchymal stem cells (MSCs) are expected to have a fundamental role in future cell-based therapies because of their high proliferative ability, multilineage potential, and immunomodulatory properties. Autologous transplantations have the...
10.
Aghayev E, Etter C, Barlocher C, Sgier F, Otten P, Heini P, et al.
Eur Spine J
. 2014 Jun;
23(10):2114-26.
PMID: 24947182
Purpose: The Swiss Federal Office of Public Health demanded a nationwide HTA registry for lumbar total disc arthroplasty (TDA), to decide about its reimbursement. The goal of the SWISS spine...